2016 Childhood Immunization Schedule Released

Share this content:
2016 Childhood Immunization Schedule Released
2016 Childhood Immunization Schedule Released

TUESDAY, Feb. 2, 2016 (HealthDay News) -- The 2016 recommended immunization schedule for children and adolescents has been approved, according to a policy statement published online Feb. 1 in Pediatrics.

Carrie L. Byington, M.D., from the American Academy of Pediatrics Committee on Infectious Diseases, and colleagues present the changes to the childhood and adolescent immunization schedule.

The researchers note that the 2016 format is similar to the 2015 schedule, with a single schedule for children from birth through age 18. Updates to the schedule include recommendations to include the nine-valent human papillomavirus (9vHPV) vaccine, which was approved in 2014 and covers nine strains of HPV. The schedule recommends HPV vaccination starting at age 11, although for children with a history of sexual abuse, who are at increased risk of HPV, vaccination should be started at age 9 years. The schedule includes a permissive recommendation for the meningococcal B vaccine for certain high-risk adolescents, with vaccination recommended as early as age 10 years. The quadrivalent meningococcal vaccine is recommended for all adolescents aged 11 to 12 years, with a booster at age 16.

"These schedules are revised annually to reflect current recommendations for use of vaccines licensed by the U.S. Food and Drug Administration," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »